Amid rising concerns over a potentially severe Ebola outbreak that has claimed nearly 250 lives and exceeds 1,000 suspected cases, three different vaccines—developed by the International Aids Vaccine Initiative, Moderna, and the University of Oxford—are in the pipeline to combat the Bundibugyo species of the virus, which lacks an approved vaccine. #EbolaVaccine #PublicHealth #EpidemicResponse








